GenVec claims encouraging results from HIV vaccine study
7th Sep 2005, 18:53 GMT
Preliminary data from an early study of an HIV vaccine developed by GenVec and the federal government shows the vaccine is well tolerated and produces a vigorous immune response, GenVec announced Wednesday.
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- United BioSource makes 10th buy, looks for more
- Nonprofits starting to invest in drug companies
- Accentia making changes to its business formula, market focus
- GSK terminates agreement for Genaera frog product
- Gladstone and Merck team to bring drugs to market
- Abbott expects to double vascular business sales
- Mayo to shut down drug-testing unit
- MIT, Dana-Farber win major cancer grants
- Service Bancorp chair resigns
- Introgen strikes nanotech deal with M.D. Anderson